Chemoinformaics analysis of Phosphoserine
Molecular Weight | 185.072 | nRot | 4 |
Heavy Atom Molecular Weight | 177.008 | nRig | 26 |
Exact Molecular Weight | 185.009 | nRing | 0 |
Solubility: LogS | -4.432 | nHRing | 0 |
Solubility: LogP | 5.97 | No. of Aliphatic Rings | 0 |
Acid Count | 3 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 19.8863 |
nHD | 4 | BPOL | 18.7677 |
QED | 0.257 |
Synth | 4.99 |
Natural Product Likeliness | 2.689 |
NR-PPAR-gamma | 0.008 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.248 |
Pgp-sub | 0.004 |
HIA | 0.018 |
CACO-2 | -4.785 |
MDCK | 0.0000205 |
BBB | 0.059 |
PPB | 0.972364 |
VDSS | 1.44 |
FU | 0.0180723 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.346 |
CYP2c19-inh | 0.009 |
CYP2c19-sub | 0.913 |
CYP2c9-inh | 0.048 |
CYP2c9-sub | 0.253 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.348 |
CYP3a4-inh | 0.085 |
CYP3a4-sub | 0.46 |
CL | 5.939 |
T12 | 0.016 |
hERG | 0.04 |
Ames | 0.068 |
ROA | 0.039 |
SkinSen | 0.019 |
Carcinogencity | 0.038 |
EI | 0.005 |
Respiratory | 0.72 |
NR-Aromatase | 0.113 |
Antiviral | No |
Prediction | 0.904322 |